.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Poster

PS2-NO-A41

Utility of DNA-methylation profiling and Integrated Molecular-Morphologic Meningioma classification as a prognostic biomarker in CNS WHO grade 2 meningiomas – a retrospective feasibility study in a patient cohort with resected meningiomas in New Zealand

Beitrag in

Neurooncology self study Meningioma and other non-glial tumors

Posterthemen

Neurooncology self study

Meningioma and other non-glial tumors

Mitwirkende

Fouzia Ziad (Hamilton, NZ), Tania Slatter (Dunedin, NZ), Greg Jones (Dunedin, NZ), Adriana Saraiva (Dunedin, NZ), Ziad Thotathil (Hamilton, NZ), Monish Maharaj (Hamilton, NZ), Basharat Bhat (Dunedin, NZ), Peter Gan (Hamilton, NZ), Noelyn Hung (Dunedin, NZ), Michael Jameson (Hamilton, NZ)